Introduction As peptide engineering has progressed, researchers have continued to investigate new ways of studying complex biological signalling systems. One question that frequently arises is why Retatrutide was developed after Tirzepatide and what scientific questions it was intended to explore. Although both peptides originated from research programmes at Eli Lilly, they were designed with different...Read More

Introduction Mounjaro and Retatrutide are frequently mentioned together in discussions about peptide research, leading many people to wonder whether they are the same compound or whether one was developed from the other. Although they are closely related through the evolution of metabolic peptide research, they are different molecules with different receptor profiles and different roles...Read More

Introduction A question that frequently appears online is whether Retatrutide is better than Mounjaro. Because both peptides are associated with metabolic research and were developed through research programmes at Eli Lilly, they are often compared. However, the answer is not straightforward. Retatrutide and Mounjaro are different molecules with different receptor profiles, and whether one is...Read More

Introduction As interest in next-generation peptide research grows, one question appears frequently: Will Retatrutide replace Mounjaro? The comparison is understandable. Mounjaro contains the active peptide Tirzepatide, while Retatrutide is a newer engineered peptide that has attracted attention because of its different receptor profile. Although they are related through the evolution of peptide research, they are...Read More

Introduction Tirzepatide and Retatrutide are two engineered peptides that have attracted significant attention in metabolic research. Both were developed through research programmes at Eli Lilly and both are designed to interact with multiple biological receptors. However, they are distinct molecules with different structural designs and receptor profiles. Because of these differences, researchers frequently compare Tirzepatide...Read More

Introduction As interest in peptide research continues to grow, two names are frequently compared: Mounjaro and Retatrutide. Although both are associated with research into metabolic biology and were developed by Eli Lilly, they are not the same molecule. The key distinction is that Mounjaro is the brand name of a medicine containing Tirzepatide, whereas Retatrutide...Read More

Introduction If you’ve been researching peptides or reading about metabolic research, you’ve probably come across both the terms Mounjaro and Tirzepatide. Because they are closely connected, many people assume they are different compounds. In reality, the difference is much simpler. Tirzepatide is the scientific (generic) name of the peptide, while Mounjaro is the brand name...Read More

Introduction One of the most common questions asked online is whether Mounjaro and Tirzepatide are the same thing. The two names are often used interchangeably, which can cause confusion for people reading scientific literature or researching peptide biology. The simple answer is that Mounjaro is the brand name, while Tirzepatide is the name of the...Read More

Introduction Every molecule has a chemical formula that summarises the types and numbers of atoms it contains. For peptides, the chemical formula forms part of the molecule’s analytical identity and is routinely referenced in scientific literature, laboratory documentation and quality control procedures. Tirzepatide is an engineered peptide with a precisely defined chemical composition. Understanding its...Read More

Introduction As peptide engineering has advanced, researchers have developed compounds capable of interacting with more than one biological receptor. This has led to growing scientific interest in both dual receptor agonists and triple receptor agonists. Retatrutide is one of the best-known examples of a triple receptor agonist. Understanding how it compares with dual receptor agonists...Read More